Testing methylphenidate for lasting tiredness in young brain tumor survivors
Original title: Methylphenidate in Pediatric Brain Tumor Survivors With Cancer-related Fatigue
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is a large, late stage trial in people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests if a drug can ease lasting tiredness in young brain tumor survivors.
Who this trial is for. This trial is for children and teens who had a brain tumor and now feel very tired. It tests a drug called methylphenidate to see if it helps that tiredness and helps thinking.
Where it stands. The trial has not reported results. It is measuring changes in tiredness and in thinking. The answer is not in yet.
What this means, and what it doesn't
What it could mean: Lasting tiredness after a brain tumor is common, and there is no proven way to treat it. This trial is looking for one. A family that fits the trial could ask their care team about it.
What it doesn't mean: This does not mean the drug works for tiredness. A trial is a test, not a proven treatment. Being in one is not a guarantee that it will help. It is not a promise of a cure.
Source: ClinicalTrials.gov, November 3, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.